Company Filing History:
Years Active: 2000
Title: Pavel Novotny: A Legacy in Antigenic Preparations
Introduction
Pavel Novotny was a notable inventor known for his contributions to the field of antigenic preparations. His work focused on the isolation of antigens from Bordetella pertussis, which has significant implications in medical research and vaccine development. Despite his passing, his innovative spirit continues to inspire future generations of scientists and inventors.
Latest Patents
Pavel Novotny held a patent for a method of deriving an antigen from Bordetella pertussis. This patent, characterized by a relative molecular weight of about 67,000 to 73,000 as determined by 12% (w/w) polyacrylamide gel electrophoresis, outlines a process that includes culturing Bordetella pertussis cells, treating the culture to obtain an outer membrane fraction, and isolating the antigen from this fraction. His patent is a testament to his expertise and dedication to advancing medical science. He is credited with 1 patent.
Career Highlights
Throughout his career, Pavel Novotny made significant strides in the field of microbiology and immunology. His work at Medeva Pharma Limited allowed him to collaborate with other experts in the field, further enhancing his contributions to antigenic research. His innovative methods have paved the way for advancements in vaccine development and disease prevention.
Collaborations
Pavel Novotny worked alongside several talented individuals, including Jaroslava Novotny, who served as an administrator, and Juan Antonio Crespo. These collaborations enriched his research and helped to foster a productive environment for innovation.
Conclusion
Pavel Novotny's legacy in the field of antigenic preparations remains influential. His innovative methods and dedication to research have left a lasting impact on the scientific community. His contributions continue to be recognized and appreciated in the ongoing pursuit of medical advancements.